Bruker Corporation manufactures and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates in two segments, Bruker Scientific Instruments, and Bruker Energy & Supercon Technologies. It offers life science tools based on magnetic resonance technology; life science mass spectrometry and ion mobility spectrometry solutions; infrared spectroscopy and radiological/nuclear detectors for chemical, biological, radiological, nuclear, and explosive detection in emergency response, homeland security, and defense applications; and research, analytical, and process analysis instruments and solutions based on infrared and Raman molecular spectroscopy technologies.
Read More…
Industry, Sector and Symbol
Industry Analytical instruments
Sub-IndustryLife Sciences Tools & Services
SectorComputer and Technology
Phone978-663-3660
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$1.90 billion
Profitability
Miscellaneous
Employees6,870
Next Earnings Date2/26/2020 (Estimated)
OptionableOptionable
Bruker (NASDAQ:BRKR) Frequently Asked Questions
What is Bruker's stock symbol?
Bruker trades on the NASDAQ under the ticker symbol "BRKR."
How often does Bruker pay dividends? What is the dividend yield for Bruker?
Bruker declared a quarterly dividend on Friday, February 21st. Investors of record on Monday, March 9th will be given a dividend of $0.04 per share on Friday, March 20th. This represents a $0.16 annualized dividend and a yield of 0.32%. The ex-dividend date of this dividend is Friday, March 6th. View Bruker's Dividend History.
How were Bruker's earnings last quarter?
Bruker Co. (NASDAQ:BRKR) posted its earnings results on Thursday, October, 31st. The medical research company reported $0.43 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $0.38 by $0.05. The medical research company had revenue of $521.10 million for the quarter, compared to analysts' expectations of $493.52 million. Bruker had a net margin of 10.20% and a return on equity of 28.02%. Bruker's quarterly revenue was up 11.7% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.37 EPS. View Bruker's Earnings History.
When is Bruker's next earnings date?
What price target have analysts set for BRKR?
13 equities research analysts have issued 12-month price objectives for Bruker's stock. Their forecasts range from $43.00 to $63.00. On average, they expect Bruker's stock price to reach $52.58 in the next year. This suggests a possible upside of 6.1% from the stock's current price. View Analyst Price Targets for Bruker.
What is the consensus analysts' recommendation for Bruker?
13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Bruker in the last year. There are currently 4 hold ratings, 8 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Bruker.
Has Bruker been receiving favorable news coverage?
Media headlines about BRKR stock have been trending very negative recently, according to InfoTrie Sentiment Analysis. The research group identifies positive and negative news coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Bruker earned a media sentiment score of -3.5 on InfoTrie's scale. They also gave press coverage about the medical research company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the company's share price in the near future. View News Stories for Bruker.
Are investors shorting Bruker?
Bruker saw a increase in short interest during the month of January. As of January 31st, there was short interest totalling 2,630,000 shares, an increase of 9.6% from the January 15th total of 2,400,000 shares. Based on an average trading volume of 526,000 shares, the days-to-cover ratio is currently 5.0 days. Approximately 2.6% of the company's shares are sold short. View Bruker's Current Options Chain.
Who are some of Bruker's key competitors?
Some companies that are related to Bruker include Thermo Fisher Scientific (TMO), Illumina (ILMN), Agilent Technologies (A), Mettler-Toledo International (MTD), Waters (WAT), Bio-Rad Laboratories (BIO), PerkinElmer (PKI), Charles River Laboratories Intl. (CRL), BIO-TECHNE (TECH), Cambrex (CBM), Luminex (LMNX), Pacific Biosciences of California (PACB), Fluidigm (FLDM), Harvard Bioscience (HBIO) and aTyr Pharma (LIFE).
What other stocks do shareholders of Bruker own?
Who are Bruker's key executives?
Bruker's management team includes the folowing people:
- Dr. Frank H. Laukien, Chairman, CEO & Pres (Age 59)
- Mr. Gerald N. Herman, CFO, VP & Corp. Controller (Age 61)
- Dr. Mark R. Munch, Exec. VP and Pres of Bruker Nano Group & Bruker Nano Surfaces Division (Age 57)
- Mr. Juergen Srega, Pres of Bruker CALID Group & Bruker Daltonics Division (Age 64)
- Dr. Falko Busse, Exec. Officer (Age 52)
Who are Bruker's major shareholders?
Bruker's stock is owned by many different of institutional and retail investors. Top institutional investors include FMR LLC (10.78%), Janus Henderson Group PLC (2.42%), Acadian Asset Management LLC (1.88%), Alliancebernstein L.P. (1.08%), Geode Capital Management LLC (0.96%) and State Street Corp (0.95%). Company insiders that own Bruker stock include Burkhard Prause, Frank H Laukien, Marc A Kastner and Mark Munch. View Institutional Ownership Trends for Bruker.
Which institutional investors are selling Bruker stock?
BRKR stock was sold by a variety of institutional investors in the last quarter, including AJO LP, Acadian Asset Management LLC, AQR Capital Management LLC, First Trust Advisors LP, Los Angeles Capital Management & Equity Research Inc., Thrivent Financial for Lutherans, MERIAN GLOBAL INVESTORS UK Ltd and MERIAN GLOBAL INVESTORS UK Ltd. Company insiders that have sold Bruker company stock in the last year include Burkhard Prause, Frank H Laukien, Marc A Kastner and Mark Munch. View Insider Buying and Selling for Bruker.
Which institutional investors are buying Bruker stock?
BRKR stock was bought by a variety of institutional investors in the last quarter, including FMR LLC, Goldman Sachs Group Inc., Mackay Shields LLC, Man Group plc, TD Asset Management Inc., Mckinley Capital Management LLC Delaware, Geode Capital Management LLC and Alliancebernstein L.P.. View Insider Buying and Selling for Bruker.
How do I buy shares of Bruker?
Shares of BRKR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Bruker's stock price today?
One share of BRKR stock can currently be purchased for approximately $49.58.
How big of a company is Bruker?
Bruker has a market capitalization of $7.63 billion and generates $1.90 billion in revenue each year. The medical research company earns $179.70 million in net income (profit) each year or $1.40 on an earnings per share basis. Bruker employs 6,870 workers across the globe.View Additional Information About Bruker.
What is Bruker's official website?
How can I contact Bruker?
Bruker's mailing address is 40 Manning Road, Billerica MA, 01821. The medical research company can be reached via phone at 978-663-3660 or via email at [email protected]
MarketBeat Community Rating for Bruker (NASDAQ BRKR)
MarketBeat's community ratings are surveys of what our community members think about Bruker and other stocks. Vote "Outperform" if you believe BRKR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BRKR will underperform the S&P 500 over the long term. You may vote once every thirty days.
